Nick Williams
Consultant
Corporate
Corporate Consultant Nick Williams provides corporate and commercial advice to UK and international public and private companies and financial advisory firms. His expertise includes mergers and acquisitions, public takeovers, corporate finance, flotations (Official List/LSE Main Market, AIM and AQSE Growth Market), fundraisings on and off market, joint ventures, corporate governance and funds. His expertise spans a range of sectors, including, in particular, financial services, real estate, healthcare, retail, renewables and natural resources. Much of his work involves international businesses.
Nick works primarily in our London office but also collaborates closely with colleagues in our other locations.
Work highlights
INVESTMENT
Advising Jiangxi Copper (Hong Kong) Investment Company Limited in relation to its US$31,000,000 investment in SolGold plc, the London and TSX-listed resources company.
STOCK EXCHANGE LISTING
Acting for Aura Renewable Acquisitions Plc on its admission to the Standard Segment of the Financial Conduct Authority’s Official List and the London Stock Exchange’s Main Market.
INVESTMENT
Advising an investor on its c. US$265,000,000 investment in an offshore fund and subsequent restructuring of the fund structure.
CORPORATE ADVISORY
Acting for Dowgate Capital Limited in its role as corporate adviser and broker to Otaq plc (OTAQ) on a £3.6m fundraising and the admission of OTAQ’s ordinary shares to trading on the Access Segment of the AQSE Growth Market.
SALE
Acting for a shareholder in relation to the sale of a company which owned and operated a Formula 1 racing team.
AIM IPOs
Advising numerous businesses on their AIM IPOs, including Kada Technology Holdings Limited, Financial Payment Systems Limited, Cosmedia Group Holdings Limited, Jetion Holdings Limited, China Medical System Holdings Limited, Green & Smart Holdings plc, Pan Pacific Aggregates plc, Yangtze China Investment Limited and Rare Earths Global Limited.
SPINOUT AND FINANCING
Advising Greenlane Renewables Inc., a TSX listed Canadian company on the English law aspects of its spinout from Pressure Technologies plc and concurrent $8.4m financing.
fundraising
Advising the underwriters on the English law/AIM Rules aspects of an initial public offering by GW Pharmaceuticals plc of American Depository Shares (“ADSs”) on the NASDAQ Global Market to raise $32.7m and a follow on offering by GW Pharmaceuticals plc of ADSs on NASDAQ to raise $101.1m.
overseas sale
Advising the shareholders of a logistics company on its sale to an overseas buyer.
CONVERTIBLE BONDS
Advising WH Ireland Limited as joint broker to Defenx plc in relation to an offer of convertible bonds and shares raising gross proceeds of £2.99m.
FUNDRAISING
Advising Optiva Securities Limited on its role as broker to Asiamet Resources Limited in a £10m equity fundraising on AIM.
ACQUISITIONS
Advising an IFA business on its acquisitions, structuring and general corporate affairs.
BOND PROGRAMME
Advising Dozens Savings Plc on its £m 5% secured bond programme which was listed on the NEX Exchange Growth Market.
Services
Sectors
Recent articles
Insights
DMH Stallard LLP is pleased to announce that it acted for Vidac Pharma Holding Plc on its admission to trading on the Düsseldorf Stock Exchange's Open Market, Primary Market Segment.
05/01/2026
Insights
Following consultation with interested parties, including the Quoted Companies Alliance, the Financial Conduct Authority (FCA) has published its final rules to implement the Public Offers and Admissions to Trading Regulations 2024.
22/07/2025
Insights
Listed shell companies whose shares were mapped into the ‘Equity shares (shell companies)’ listing category at the end of July 2024, will have been receiving letters in recent months from the FCA’s Primary Markets Monitoring Team.
11/06/2025
Insights
The Takeover Panel has confirmed future changes to the Takeover Code which will limit the types of companies subject to the Code.
07/11/2024